POFUT1 | Protein O-fucosyltransferase 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
C20orf112 | Chromosome 20 open reading frame 112 | | | | | | Expressed in all |
MAPRE1 | Microtubule-associated protein, RP/EB family, member 1 | Plasma proteins
| | | | | Expressed in all |
SUN5 | Sad1 and UNC84 domain containing 5 | Predicted membrane proteins
| | | | | Tissue enriched |
BPIFB2 | BPI fold containing family B, member 2 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
BPIFA2 | BPI fold containing family A, member 2 | Predicted secreted proteins
| | | | | Tissue enriched |
BPIFA3 | BPI fold containing family A, member 3 | Predicted secreted proteins
| | | | | Tissue enriched |
BPIFA1 | BPI fold containing family A, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
BPIFB1 | BPI fold containing family B, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CBFA2T2 | Core-binding factor, runt domain, alpha subunit 2; translocated to, 2 | | | | | | Expressed in all |
E2F1 | E2F transcription factor 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
CHMP4B | Charged multivesicular body protein 4B | Disease related genes
| | | | | Expressed in all |
RALY | RALY heterogeneous nuclear ribonucleoprotein | Plasma proteins
| | | | | Expressed in all |
EIF2S2 | Eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
ITCH | Itchy E3 ubiquitin protein ligase | Disease related genes
| | | | | Expressed in all |
DYNLRB1 | Dynein, light chain, roadblock-type 1 | Plasma proteins
| | | | | Expressed in all |
MAP1LC3A | Microtubule-associated protein 1 light chain 3 alpha | | | | | | Expressed in all |
NCOA6 | Nuclear receptor coactivator 6 | | | | | | Expressed in all |
GSS | Glutathione synthetase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
PROCR | Protein C receptor, endothelial | Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Mixed |
EIF6 | Eukaryotic translation initiation factor 6 | Plasma proteins
| | | | | Expressed in all |
UQCC1 | Ubiquinol-cytochrome c reductase complex assembly factor 1 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ERGIC3 | ERGIC and golgi 3 | Predicted membrane proteins
| | | | | Expressed in all |
RBM12 | RNA binding motif protein 12 | | | | | | Expressed in all |
NFS1 | NFS1 cysteine desulfurase | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
RBM39 | RNA binding motif protein 39 | Plasma proteins
| | | | | Expressed in all |
MYL9 | Myosin, light chain 9, regulatory | | | | | | Expressed in all |
NDRG3 | NDRG family member 3 | Predicted membrane proteins
| | | | | Expressed in all |
DSN1 | DSN1, MIS12 kinetochore complex component | Plasma proteins
| | | | | Expressed in all |
SAMHD1 | SAM domain and HD domain 1 | Disease related genes Plasma proteins
| | | | | Expressed in all |
RBL1 | Retinoblastoma-like 1 (p107) | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
RPN2 | Ribophorin II | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BPI | Bactericidal/permeability-increasing protein | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
SLC32A1 | Solute carrier family 32 (GABA vesicular transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
TOP1 | Topoisomerase (DNA) I | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
PLCG1 | Phospholipase C, gamma 1 | Cancer-related genes Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
SRSF6 | Serine/arginine-rich splicing factor 6 | | | | | | Expressed in all |
MYBL2 | V-myb avian myeloblastosis viral oncogene homolog-like 2 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
GTSF1L | Gametocyte specific factor 1-like | | | | | | Tissue enriched |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
ADA | Adenosine deaminase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
RIMS4 | Regulating synaptic membrane exocytosis 4 | | | | | | Tissue enhanced |
YWHAB | Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
TOMM34 | Translocase of outer mitochondrial membrane 34 | Mitochondrial proteins
| | | | | Expressed in all |
PI3 | Peptidase inhibitor 3, skin-derived | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SEMG2 | Semenogelin II | Plasma proteins Predicted secreted proteins
| | | | | Not detected |
SLPI | Secretory leukocyte peptidase inhibitor | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
RBPJL | Recombination signal binding protein for immunoglobulin kappa J region-like | Transcription factors
| | | | | Tissue enriched |
SDC4 | Syndecan 4 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Expressed in all |
DBNDD2 | Dysbindin (dystrobrevin binding protein 1) domain containing 2 | | | | | | Expressed in all |